{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-012285","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.210425+00:00","generated_at":"2026-05-20T15:26:55.994449+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Biofrontera receives Nasdaq deficiency notice for equity below $2.5M","bullets":["Stockholders' equity at $469,000, well below Nasdaq's $2.5M minimum requirement.","Company has 45 days to submit a compliance plan to Nasdaq.","If plan accepted, Nasdaq may grant up to 180 days from May 21, 2025 to regain compliance.","Alternative market value or net income criteria also not met."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-012285","json":"https://secwatch.observer/filing/0001641172-25-012285.json","markdown":"https://secwatch.observer/filing/0001641172-25-012285.md","text":"https://secwatch.observer/filing/0001641172-25-012285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225012285/0001641172-25-012285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225012285/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T15:26:55.994449+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e492ee19eae710552d53da87dca7adc4b5d5827f","claim":"Biofrontera Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)).","evidence_excerpt":"May 21, 2025, Biofrontera Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the period ended March 31, 2025 was $469,000, the Company is no longer in compliance with the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company’s stockholders’ equity be at least $2,500,000. Additionally, as of the date of the Notice, the Company did not meet either of the alternative requirements of","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225012285/0001641172-25-012285-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1), 5550(b)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}